European Medicines Agency opens public discussion on need for active control in clinical trials

News 12/01/2011

The European Medicines Agency (EMA) has published a PDF iconreflection paper on the need for active control in therapeutic areas where use of a placebo is deemed ethical and one or more established medicines are available. The reflection paper is open for public consultation until 31 March 2011.

The paper outlines a framework for the discussion and justification of the choice of control arms that is expected from an applicant in a centralised marketing authorisation application.

How useful was this page?

Add your rating